Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy

Low skeletal muscle mass (SMM) is associated with toxicities and decreased survival in head and neck cancer (HNC). Chemoradiotherapy (CRT) may exaggerate loss of SMM. We investigated the changes in SMM, their predictors, and prognostic impact of SMM in patients treated with CRT between 2012 and 2018...

Descripción completa

Detalles Bibliográficos
Autores principales: Chargi, Najiba, Wegner, Inge, Markazi, Navid, Smid, Ernst, de Jong, Pim, Devriese, Lot, de Bree, Remco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074083/
https://www.ncbi.nlm.nih.gov/pubmed/33919607
http://dx.doi.org/10.3390/jcm10081762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074083/
https://www.ncbi.nlm.nih.gov/pubmed/33919607
http://dx.doi.org/10.3390/jcm10081762

Ejemplares similares